Summary
To define their efficacy and mechanism of action, the possible antagonistic effects of intravenously administered dextrorphan and dizocilpine, non-competitive N-methyl-d-aspartic acid (NMDA) receptor antagonists, on tonic convulsions and death in a variety of experimental mice models were compared.
Dextrorphan not only produced dose-dependent protection against the tonic convulsions caused by an intracerebroventricular injection of NMDA, but also showed a broad spectrum of anticonvulsant activities against tonic convulsions caused by α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), kainic acid (KA), bicuculline, pentylenetetrazole or electroconvulsive shock. The anticonvulsant action of dizocilpine was found to be more efficacious for any type of tonic convulsions and was 20- to 70-fold more potent than that of dextrorphan. Dizocilpine, unlike dextrorphan, impaired motor function at doses showing its anticonvulsant activity. Bay k-8644 (a Ca 2+ channel agonist)-induced seizures were not antagonized by dextrorphan. Dextrorphan and dizocilpine were characteristically selective for protective functions against death, especially with three subtypes of glutamate receptors, as death caused by NMDA but not by AMPA and KA was selectively and markedly inhibited by both dextrorphan and dizocilpine.
In view of these results, the efficacy of dextrorphan and dizocilpine as antagonists of convulsant effects appears to be consistent with the interpretation that a variety of convulsants cause tonic convulsions via direct or indirect interaction with the NMDA receptor complex. Furthermore, it is suggested that influx of Ca2+ and intracellular Ca2+ activity, such as the Bay k-8644-modulated activation of Ca2+ binding proteins, are not directly modified by the administration of dextrorphan, itself.
Similar content being viewed by others
References
Akaike N, Imai M, Mishima K, Watanabe H, Rob J, Tanaka Y, Himori N (1991) Biological profile of dextrorphan, an N-methyl-d-aspartate receptor antagonistic cerebroprotectant. In: Kameyama T, Nabeshima T, Domino E (eds) NMDA receptor related agents; biochemistry, pharmacology and behavior. NPP Books, Ann Arbor, pp 337–344
Akaike N, Himori N (1992) Effects of a variety of compounds on tonic convulsions and death induced by centrally administered convulsants: involvement of NMDA and Ca2+ channels in convulsant actions. Jpn J Pharmacol 58:320P
Allaoua H, Chicheportiche R (1989) Anaesthetic properties of phencyclidine (PCP) and analogues may be related to their interaction with Na+ channels. Eur J Pharmacol 163:327–335
Bolger GT, Rafferty MF, Skolnick P (1986) Enhancement of brain calcium antagonist binding by phencyclidine and related compounds. Pharmacol Biochem Behav 24:417–423
Carpenter CL, Marks SS, Watson DL, Greenberg DA (1988) Dextromethorphan and dextrorphan as calcium channel antagonists. Brain Res 439:372–375
Choi DW, Peter S, Viseskul V (1987) Dextrorphan and levorphanol selectively block N-methyl-d-aspartate receptor-mediated neurotoxicity on cortical neurons. J Pharmacol Exp Ther 242:713–720
Clark WG, Vivonia CA, Baxter CF (1968) Accurate free-hand injection into the lateral brain ventricle of the conscious mouse. J Appl Physiol 25:319–321
Cole AE, Eccles CU, Aryanpur JJ, Fisher RS (1989) Selective depression of N-methyl-d-aspartate-mediated responses by dextrorphan in the hippocampal slice in rat. Neuropharmacol 28:249–254
Ferkany SW, Borosky SA, Clissold DB, Pontecorvo MJ (1988) Dextromethorphan inhibits NMDA-induced convulsions. Eur J Pharmacol 151:151–154
Feeser HR, Kadis JL, Prince DA (1988) Dextrorphan, a common antitussive, reduces kindled amygdala seizures in the rat. Neurosci Lett 86:340–345
Herron CE, Williamson R, Collingridge GL (1985) A selective N-methyl-d-aspartate antagonist depresses epileptiform activity in rat hippocampal slices. Neurosci Lett 61: 255–260
Himori N, Watanabe H, Akaike N, Kurasawa M, Rob J, Tanaka Y (1990) Cerebral ischemia model with conscious mice: involvement of NMDA receptor activation and derangement of learning and memory ability. J Pharmacol Methods 23:311–327
Himori N, Moreau JL, Martin JR (1991) Cerebral ischemia decreases the behavioral effects and mortality rate elicited by activation of NMDA receptors in mice. Neuropharmacology 30:1179–1186
Himori N, Imai M, Akaike N, Matsukura T, Watanabe H (1992) Replenishment of brain adenosine triphosphate content by morphinan-type N-methyl-d-aspartate receptor antagonists, dextrorphan and dextromethorphan through the activation of adenylate kinase. Arzneim-Forsch/Drug Res 42:595–598
Himori N, Tanaka Y, Kurasawa M, Mishima K, Akaike N, Ueno K, Matsukura T, Watanabe H (1993) Dextrorphan attenuates the behavioral consequences of ischemia and the biochemical consequences of anoxia: possible role of N-methyl-d-aspartate receptor antagonism and ATP replenishing action in its cerebroprotecting profile. Psychopharmacology (in press)
Koek W Colpaert FC (1989) Selective blockade of N-methyl-d-aspar-tate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects. J Pharmacol Exp Ther 252:349–357
Leander JD, Rathbun RC, Zimmerman DM (1988) Anticonvulsant effects of phencyclidine-like drugs: relation to N-methyl-d-aspartic acid antagonism. Brain Res 454:368–372
Little HJ (1982) Effects of ketamine and of high pressure on the responses to γ amino-butyric acid of the rat superior cervical ganglion in vitro. Br J Pharmacol 77:209–216
Loo PS, Braunwalder AF, Lehmann J, Williams M, Sills MA (1987) Interaction of L-glutamate and magnesium with phencyclidine recognition sites in rat brain: evidence for multiple affinity states of the phencyclidine/N-methyl-d-aspartate receptor complex. Molecular Pharmacol 32:820–830
Moreau JL, Pieri L, Prud'hon B (1989) Convulsions induced by centrally administered NMDA in mice: effects of NMDA antagonists, benzodiazepines, minor tranquilizers and anticonvulsants. Br J Pharmacol 98:1050–1054
Musacchio JM, Klein M, Santiago LJ (1988) High affinity dextromethorphan binding sites in guinea pig brain: further characterization and allosteric interactions. J Pharmacol Exp Ther 247:424–431
Myslobodsky MS, Golovchinsky V, Mintz M (1981) Ketamine: convulsant or anticonvulsant? Pharmacol Biochem Behav 14:27–33
Pellmar TC, Wilson WA (1977) Synaptic mechanism of pentylenetetrazole: selectivity for chloride conductance. Science 26:912–914
Steinberg GK, Saleh J, Kunis D, DeLaPaz R, Zarnegar BR (1989) Protective effect of N-methyl-d-aspartate antagonists after focal cerebral ischemia in rabbits. Stroke 20:1247–1252
Swan JH, Meldrum BS (1990) Protection by NMDA antagonists against selective cell loss following transient ischemia. J Cereb Blood Flow Metab 10:343–351
Thompson AM, West DC (1985) Picrotoxin-induced epileptiform discharges in slices of rat cerebral cortex is not blocked by NMDA antagonists. J Physiol 364:31P
Tortella FC, Ferkany JW, Pontecorvo JJ (1988) Anticonvulsant effects of dextrorphan in rats: possible involvement in dextromethorphan-induced seizure protection. Life Sci 42:2509–2514
Wong EHF, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL (1986) The anticonvulsant MK-801 is a potent N-methyl-d-aspartate antagonist. Proc Natl Acad Sci 83:7104–7108
Wong EHF, Knight AR, Woodruff GN (1988) [H]MK-801 labels a site on the N-methyl-d-aspartate receptor channel complex in rat brain membranes. J Neurochem 50:274–281
Woodruff GN, Foster AC, Gill R, Kemp JA, Wong EHF, Iversen LL (1987) The interaction between MK-801 and receptors for N-methyI-d-aspartate: functional consequences. Neuropharmacology 26:903–909
Yashima Y, Kato H, Kogure K (1991) Postischemic selective neuronal damage: NMDA antagonists and beyond. In: Kameyama T, Nabeshima T, Domino E (eds) NMDA receptor related agents; biochemistry, pharmacology and behavior. NPP Books, Ann Arbor, pp 345–350
Author information
Authors and Affiliations
Additional information
Correspondence to: N. Himori at the above address
Rights and permissions
About this article
Cite this article
Akaike, N., Himori, N. Antagonism of various tonic convulsions in mice by dextrorphan and dizocilpine. Naunyn-Schmiedeberg's Arch Pharmacol 347, 652–657 (1993). https://doi.org/10.1007/BF00166949
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00166949